Molbio Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 2.26 Cr
- Company Age 24 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 200.20 Cr
- Satisfied Charges ₹ 242.87 Cr
- Revenue Growth -38.61%
- Profit Growth -55.30%
- Ebitda -47.40%
- Net Worth 96.73%
- Total Assets 9.00%
About Molbio Diagnostics
Molbio Diagnostics Private Limited (MDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 October 2000 and has a history of 24 years and four months. Its registered office is in Goa, Goa, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 2.26 Cr.
The company currently has active open charges totaling ₹200.20 Cr. The company has closed loans amounting to ₹242.87 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Molbio Diagnostics Private Limited India are Sriram Natarajan as Ceo, Amol Lone as Cfo, and Darshan Karekar as Company Secretary. Sriram Natarajan, Chandrasekhar Nair, Sangeetha Sriram, and Three other members serve as directors at the Company.
Company Details
- Location
Goa, Goa, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33125GA2000PTC002909
- Company No.
002909
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2000
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
What products or services does Molbio Diagnostics Private Limited offer?
Molbio Diagnostics Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit, PCR Machine, Rapid Test Kit.
Who are the key members and board of directors at Molbio Diagnostics?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sriram Natarajan | CEO | 06-Dec-2023 | Current |
| Amol Lone | CFO | 12-Sep-2024 | Current |
| Darshan Karekar | Company Secretary | 13-Sep-2024 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Mantri  | Nominee Director | 22-Jan-2020 | Current |
| Sriram Natarajan | Director | 19-Mar-2011 | Current |
| Chandrasekhar Nair | Director | 01-Aug-2011 | Current |
| Sangeetha Sriram | Director | 19-Jun-2020 | Current |
| Rohit Mullangi | Director | 14-Aug-2022 | Current |
| Ved Kalanoria | Nominee Director | 30-Dec-2023 | Current |
Financial Performance of Molbio Diagnostics.
Molbio Diagnostics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 38.61% decrease. The company also saw a substantial fall in profitability, with a 55.3% decrease in profit. The company's net worth Soared by an impressive increase of 96.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Molbio Diagnostics?
In 2022, Molbio Diagnostics had a promoter holding of 86.39% and a public holding of 13.61%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Scalene Energy - Water Corporation LimitedSriram Natarajan is a mutual person
Manipal Health Enterprises Private LimitedVed Kalanoria is a mutual person
Tarnea Technology Solutions Private LimitedSriram Natarajan is a mutual person
Dr. Agarwal's Health Care LimitedVed Kalanoria is a mutual person
Symbiotec Zenfold Private LimitedRohit Mantri is a mutual person
- Symbiotec Pharmalab Private Limited
Rohit Mantri is a mutual person
Charges (Loans)
₹200.20 Cr
₹242.87 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 102.75 Cr
- Others : 52.45 Cr
- Tata Capital Financial Services Limited : 45.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jul 2024 | Others | ₹2.75 Cr | Open |
| 17 Jul 2024 | Others | ₹2.75 Cr | Open |
| 05 Dec 2023 | Others | ₹30.00 Cr | Open |
| 03 Nov 2023 | Others | ₹15.00 Cr | Open |
| 12 Oct 2023 | Tata Capital Financial Services Limited | ₹45.00 Cr | Open |
How Many Employees Work at Molbio Diagnostics?
Molbio Diagnostics has a workforce of 616 employees as of Apr 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Molbio Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molbio Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
